Mark Chamberlin

Mark Chamberlin has extensive work experience in the legal field. Mark started their career as a lawyer at Mintz Levin in 1996, where they focused on corporate, financial institution, and securities law. Mark provided legal advice and support for transactions, corporate governance, mergers and acquisitions, securities offerings, and regulatory compliance. Mark also worked with federal regulatory agencies such as the SEC and state regulators.

In 2018, Mark joined Momenta Pharmaceuticals as an Associate General Counsel, where they continued to utilize their legal expertise. Mark was responsible for various legal matters, including providing support for corporate transactions and ensuring regulatory compliance.

Currently, Mark serves as the Corporate Counsel-Executive Director at Forma Therapeutics, starting in 2021. As the highest legal position within the company, they oversee all legal matters and provides strategic legal advice to the executive team.

Overall, Mark Chamberlin's work experience demonstrates their proficiency in corporate, financial institution, and securities law, as well as their ability to navigate complex regulatory landscapes.

Mark Chamberlin has an A.B. degree in Biochemistry and Philosophy from Bowdoin College and a J.D. degree from the University of Connecticut School of Law.